Caribou Biosciences (CRBU) Assets (2020 - 2026)
Caribou Biosciences (CRBU) reported Assets of $142.77 million for Q2 2026, down 35.4% from $220.9 million a year earlier and down 4.2% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Caribou Biosciences posted Assets of $175.37 million, down 44.0% from FY2024.
- Assets has a five-year compound annual growth rate of 37.2% (FY2020 to FY2025).
- By year, Assets came in at $313.31 million in FY2024 (-27.5%), $432.21 million in FY2023 (+15.6%), $373.77 million in FY2022 (-15.5%) and $442.36 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Assets since Q4 2020.
- Year over year, Assets has now declined in each of the last eight quarters, with an average decline of 36.8% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q2 2022 (growth of 166.0%); the low point was Q1 2026 (a decline of 45.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $149 million (Q1 2026), $175.37 million (Q4 2025) and $194.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Caribou Biosciences | 130.37 Mn | -386.16 Mn | - | 142.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142.77 Mn |
| Mar 31, 2026 | 149.00 Mn |
| Dec 31, 2025 | 175.37 Mn |
| Sep 30, 2025 | 194.98 Mn |
| Jun 30, 2025 | 220.90 Mn |
| Mar 31, 2025 | 273.66 Mn |
| Dec 31, 2024 | 313.31 Mn |
| Sep 30, 2024 | 344.33 Mn |
| Jun 30, 2024 | 372.94 Mn |
| Mar 31, 2024 | 406.83 Mn |
| Dec 31, 2023 | 432.21 Mn |
| Sep 30, 2023 | 457.52 Mn |
| Jun 30, 2023 | 349.65 Mn |
| Mar 31, 2023 | 347.46 Mn |
| Dec 31, 2022 | 373.77 Mn |
| Sep 30, 2022 | 398.82 Mn |
| Jun 30, 2022 | 421.37 Mn |
| Mar 31, 2022 | 446.00 Mn |
| Dec 31, 2021 | 442.36 Mn |
| Sep 30, 2021 | 461.96 Mn |
API Access
Caribou Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();